From 2013 to 2023, there was an increase in the proportion of US adults who were unaware of having hypertension.

HealthDay News — The artificial sweetener neotame is ubiquitous in popular disposable e-cigarettes, according to a research letter published online June 2 in the Journal of the American Medical ...

Patients with T1D experienced greater reductions in risk for cardiovascular disease with empagliflozin compared with placebo.

Asthma incidence in adults is positively associated with lipid accumulation product (LAP) levels, according to study findings published in Respiratory Medicine.

Access to patient portals increases the likelihood that patients with or at risk for cardiovascular disease will engage in shared decision-making.

There is increased use of quadruple medical therapy among patients following implementation of an HF quality improvement initiative.

For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies.

For patients with CKD and T2D, combination finerenone plus empagliflozin leads to a greater reduction in the urinary albumin-to-creatinine ratio than either agent alone.

The long-term incidence of MACE, VTE, and malignancies is low among patients with RA or UC receiving filgotinib, though a slight increase was observed among older patients.

Both CPAP and tirzepatide are acceptable treatments for comorbid obesity and OSA, with providers favoring CPAP and patients preferring tirzepatide.

Topline data were announced from two phase 3 trials evaluating enlicitide decanoate for the treatment of adults with hyperlipidemia.

Lorundrostat, a selective aldosterone synthase inhibitor, significantly reduced 24-hour systolic blood pressure in individuals with uncontrolled and treatment-resistant hypertension, according to ...